Explore more about: Breast Cancer

November 12, 2020
News
While immunotherapies work well for some cancers, others are immune-resistant and condemn patients to the severe side effects of long-term chemo treatment. A new cancer vaccine successfully treated immune-resistant breast cancer in mice, 100% of which survived a second injection of cancer cells, indicating long-term immunity with no side effects.
December 13, 2019
News
QuantX backstops radiologists with AI-enabled software that analyzes MRIs to confirm or challenge their diagnosis.
October 22, 2019
News
Learn about Dr. Carla Pugh's scientific accomplishments throughout her career journey and her advice for women scientists.
December 3, 2020
News
Macrophages are white blood cells that accumulate in tumors, where they aid cancer progression. Now scientists have identified a surface protein found only on the macrophages residing in tumors, exposing a target for precise tumor treatments.
December 3, 2020
News
NIBIB-funded researchers used photoacoustic imaging for rapid measurement of metabolic rate of individual cells from breast tumors—information that can help guide treatment strategies.
December 3, 2020
News
NIBIB-funded researchers have created a novel, low-cost biosensor to detect HER-2, a breast cancer biomarker in the blood, allowing for a far less invasive diagnostic test than the current practice, a needle biopsy.
December 9, 2020
News
Up to 50% of women skip potentially life-saving mammograms often because the procedure can cause extreme discomfort and pain. Now researchers have developed a painless, light-based, non-radioactive, 15-second procedure that could revolutionize breast cancer screening and save lives.
December 3, 2020
News
Bioengineers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed a smart anti-cancer nanoparticle with precisely targeted tumor-killing activity superior to previous technologies.
December 3, 2020
News
NIBIB-funded researchers at Case Western Reserve University have developed a new imaging contrast agent that can detect breast cancer and could give doctors an indication of the potential aggressiveness of the cancer.
December 9, 2020
News

A new magnetic resonance imaging contrast agent being tested by researchers not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing types. Read more at The Case Western Reserve University Daily.